Everyone wants to look and feel good—thus, it is not surprising that the personal care product industry is burgeoning, estimated to be valued at over $80 billion. Within the category, the “cosmetic” subcategory is often perceived as an “easy” one to enter, given the relatively limited regulatory hurdles and oversight historically associated with cosmetics compared with conventional food, dietary supplements, devices or drugs. The past year, however, has reflected some important regulatory and legislative trends that may modify the risk calculus associated with the sale of cosmetic products in the U.S. This article highlights five key watch-outs for companies to help them manage the risk profile for their product portfolio while capitalizing on growth in the sector.
1. Increased FDA Scrutiny and Advisories
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
